Related Experiment Video

Updated: Sep 8, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma - too much skin in the

Sze Wah Samuel Chan1, Michael Au2, Adi Kartolo1,3

  • 1Department of Oncology, McMaster University, Hamilton, ON, Canada.

Immunotherapy
|July 1, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Neoadjuvant immune-checkpoint inhibitorPET-CTmajor pathological responsemetabolic responsepathological responsestage III melanoma

More Related Videos

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.1K
Intralymphatic Immunotherapy and Vaccination in Mice07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658